[Hepatocellular carcinoma: tumoral or peritumoral disease?]
Abstract:
Hepatocellular carcinoma (HCC) is a highly malignant cancer with prognosis and survival still poor mainly because of HCC reoccurrence and cancer metastasis. No drugs are so far available to reduce or block HCC progression, likely because the molecular mechanisms involved in cancer proliferation and spread are mainly unknown. In this review, we will discuss the role of the tissue microenvironment in affecting HCC clinical outcome. Therefore, based on new pathogenetic findings, tissue microenvironment will be considered as potential target for new therapeutic approaches. The aim of this review is to stimulate the debate on the translational research in the HCC field.
Related Concept Videos
Cirrhosis II: Pathophysiology
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis I: Introduction
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment


